中国P站

Orthopaedic oncology; Multidisciplinary cancer care; Bone tumors; Limb salvage surgery; Sarcoma management; Metastatic bone disease; Reconstructive surgery; Oncology collaboration; Surgical oncology; Cancer rehabilitation

Introduction

The landscape of cancer care has evolved dramatically over the past several decades, emphasizing multidisciplinary collaboration to provide holistic, patient-centered treatment. Among the many specialties contributing to this model, orthopaedic oncology plays a critical and increasingly central role in the diagnosis, surgical management, and rehabilitation of patients with primary and secondary bone malignancies [1]. Historically, musculoskeletal tumors were managed with radical amputations and limited reconstructive possibilities. However, advances in imaging, pathology, surgical techniques, and systemic therapies have redefined the scope of orthopaedic oncology, shifting the paradigm toward limb-sparing surgeries and functional preservation. As cancer survival improves, the demand for durable orthopedic interventions that support both oncologic control and quality of life continues to grow [2].

Description

Orthopaedic oncologists specialize in the evaluation and surgical treatment of benign and malignant musculoskeletal tumors, including primary bone sarcomas, soft tissue sarcomas, and metastatic bone disease. Their expertise extends to complex reconstructive procedures, biomechanical planning, and postoperative rehabilitation strategies. The integration of orthopaedic oncology into cancer care teams enhances early diagnosis, facilitates timely biopsy and staging, and ensures appropriate surgical margins and oncologic principles are upheld during tumor resections [3].

One of the most notable contributions of orthopaedic oncology is the development of limb-salvage surgery, which has become the standard of care for many patients with extremity sarcomas. Innovations in endoprosthetic reconstruction, allografts, vascularized bone transfers, and custom 3D-printed implants have expanded the reconstructive toolbox, allowing for better functional outcomes without compromising oncologic safety. These techniques require precise preoperative planning, often involving advanced imaging modalities, computer-assisted surgery, and close coordination with plastic and vascular surgeons [4].

Beyond primary sarcomas, orthopaedic oncologists are increasingly managing metastatic bone disease, particularly from cancers such as breast, prostate, lung, and kidney. These patients often present with painful skeletal lesions or impending pathological fractures, requiring urgent stabilization or reconstruction to maintain mobility and reduce morbidity. Collaboration with medical and radiation oncologists is essential to determine the timing of surgery, systemic therapy, and palliative care [5].

Orthopaedic oncology also plays a pivotal role in cancer diagnosis and surveillance. Accurate biopsy techniques performed by experienced specialists help avoid contamination of uninvolved tissues and ensure proper pathological evaluation. Radiographic and nuclear imaging, in conjunction with multidisciplinary tumor boards, supports comprehensive staging and treatment planning. In pediatric oncology, where bone tumors like osteosarcoma and Ewing sarcoma are most prevalent, orthopaedic oncologists coordinate closely with pediatric oncologists to balance aggressive treatment with growth and developmental considerations [6].

Discussion

The inclusion of orthopaedic oncologists in multidisciplinary cancer teams represents a shift toward integrative oncology, where specialists collaborate to create individualized care pathways. Tumor boards have become essential forums for treatment planning, bringing together expertise in surgery, medical oncology, radiation oncology, pathology, radiology, and rehabilitation. Orthopaedic oncologists contribute not only surgical insight but also prognostic and functional assessments that guide decision-making and patient counselling [7]. Challenges persist in the coordination of care, particularly in resource-limited settings where access to specialized surgical expertise and prosthetic technologies may be limited. Additionally, the complexity of musculoskeletal tumors often necessitates referral to high-volume centers with experienced multidisciplinary teams. Telemedicine and virtual tumor boards have emerged as valuable tools to bridge geographical gaps and enhance collaboration across institutions [8].

From a surgical perspective, balancing oncologic control with functional preservation remains a delicate endeavor. Inadequate margins increase recurrence risk, while overly aggressive resections can lead to unnecessary disability. Advances in intraoperative navigation, tumor mapping, and personalized implants have improved accuracy and outcomes. Moreover, postoperative rehabilitation is critical to maximizing recovery, underscoring the need for coordinated physical therapy and long-term follow-up. In recent years, the role of orthopaedic oncology has expanded into translational research and precision medicine. Molecular profiling of tumors has enabled targeted therapies that complement surgical treatment and improve survival. Liquid biopsy, genetic testing, and biomarkers offer new avenues for monitoring disease progression and treatment response. Orthopaedic oncologists contribute to clinical trials and research initiatives that aim to refine treatment algorithms and develop less invasive interventions [9]. The psychosocial and emotional burden of musculoskeletal cancers also necessitates compassionate, holistic care. Amputations, even when avoidable, may carry profound psychological impact. Orthopaedic oncologists often serve as advocates for patients, ensuring that surgical decisions reflect both oncologic necessity and patient preference. Integration of mental health services and survivorship programs is essential to address the broader implications of cancer treatment [10].

Conclusion

The field of orthopaedic oncology has evolved from a niche surgical specialty to a cornerstone of multidisciplinary cancer care. By combining surgical innovation, reconstructive expertise, and collaborative practice, orthopaedic oncologists have significantly improved outcomes for patients with musculoskeletal tumors. As cancer care continues to advance, the role of orthopaedic oncology will expand further, incorporating precision medicine, advanced imaging, and patient-centered rehabilitation. Continued investment in training, research, and interdisciplinary collaboration is essential to sustaining this progress and ensuring that patients receive the highest standard of care. Ultimately, the evolving role of orthopaedic oncology reflects the broader transformation of cancer care—toward integration, innovation, and individualized treatment.

References

1. Olsen LF, Issinger OG, Guerra B (2013) . Redox Rep 18: 245-252.

   , ,

2. Pernas L, Scorrano L (2016) . Annu Rev Physiol 78: 505-531.

   , ,

3. Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW, et al (2017) . J Pathol 241: 236-250.

   , ,

4. Ong SB, Kalkhoran SB, Hernandez-Resendiz S, Samangouei P, Ong SG, et al. (2017) . Cardiovasc Drugs Ther 31: 87-107.

   , ,

5. Yu T, Robotham JL, Yoon Y (2006) . Proc Natl Acad Sci U S A 103: 2653-2658.

   , ,

6. Jheng HF, Tsai PJ, Guo SM, Kuo LH, Chang CS, et al. (2012) . Mol Cell Biol 32: 309-319.

   , ,

7. Tailor D, Hahm ER, Kale RK, Singh SV, Singh RP (2014) . Mitochondrion 16: 55-64.

   , ,

8. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Group AHEW, et al. (2003) . Clin Nutr 22: 321-336.

   , ,

9. Marcadenti A, Mendes LL, Rabito EI, Fink JDS, Silva FM, et al. (2018) . J Parenter Enter Nutr 42: 1168-1176.

   , ,

10. Arslan M, Soylu M, Kaner G, 陌nanç N, Ba艧m谋s谋rl谋 E, et al. (2016) . Hippokratia 20: 147-152.

    ,